レジオネラ菌検査市場レポート：2031年までの動向、予測、競合分析

世界のレジオネラ菌検査市場の将来は、病院、診断研究所、水産業市場に機会がありそうです。世界のレジオネラ菌検査市場は、2025年から2031年までのCAGRが7.8%で、2031年までに推定4億8,820万米ドルに達すると予想されます。この市場の主な促進要因は、レジオネラ菌に関連した肺炎や疾患の発生が増加していることと、日常的な水質検査に関する規制が厳しくなっていることです。

• Lucintelの予測によると、用途カテゴリーでは、水質検査が予測期間中、より大きなセグメントであり続けています。
• 最終用途カテゴリーでは、水産業が予測期間中最大のセグメントであり続けると思われます。
• 地域別では、北米が予測期間中最大の地域であり続けています。

レジオネラ菌検査市場の戦略的成長機会

レジオネラ菌検査市場における戦略的成長機会は、新市場への広範な浸透や現行慣行の改善を可能にする進歩や技術革新によってもたらされる可能性があります。このような機会の世界市場は、公衆衛生目標に必要な技術改善や規制変更の可能性があるさまざまな分野を示す広範なものです。

• 先進検査技術の開発：高度な検査技術は、レジオネラ検出の感度、特異性、効率を大幅に向上させることができます。このような技術に投資することで、正確で迅速な検査結果を得ることができ、信頼性が高く迅速な検査の需要増に応えることができます。また、診断能力の拡大や全体的な疾病予防／管理にも役立ちます。
• 新興市場への進出：レジオネラ菌検査サービスを新市場に進出させることで、レジオネラ菌検査事業を拡大する大きな成長の見込みが生まれます。このような地域に焦点を当てることで、質の高い検査サービスへの一般市民のアクセス向上と新たな健康懸念への対応につながる市場拡大とより良い健康成果を促進することができます。この変化は世界の成長を促進し、疾病管理イニシアチブを強化します。
• 統合環境モニタリングシステム：レジオネラ菌検査を環境モニタリングと統合することで、水質の包括的な管理とリアルタイムのモニタリングが容易になります。そうすることで、将来の疾病を予防し、レジオネラ症発生の可能性について早期に警告することが可能になります。このような統合は、スクリーニングプログラムの全体的な有効性と信頼性を向上させます。
• 予防的かつ積極的な検査戦略の重視：水道システムの維持管理などの予防的なメンテナンス対策に集中することで、集団発生が起こる前にその原因と思われるものを特定し、対処することが容易になります。事実上、これはより強力な検査プログラムをサポートしながら、公衆衛生の成果を向上させるのに役立ちます。予防戦略への投資は、レジオネラ症に起因する症例数を減少させながら、疾病管理を改善します。
• 規制遵守ソリューションの強化：強化され続ける規則への準拠を可能にするソリューション・プラットフォームを提供することで、高品質の基準で洗練された検査方法を採用することができます。コンプライアンスメカニズムの向上は、分析業務の手段全体に関わる他の広範な変化との関連で、業界の成長を促進するために規制の課題に対処します。この機会は、より効果的な開発と信頼性の高いスクリーニングプログラムをサポートします。

先進技術の開発、新規市場への参入、環境モニタリングシステムとの統合、予防検査の重視、規制遵守の強化など、レジオネラ菌検査市場における成長機会は、市場の大幅な拡大につながる可能性があります。上記の戦略は、レジオネラ症に対するより良い管理を提供し、検査結果の精度を向上させるのに役立ちます。

レジオネラ菌検査市場の促進要因・課題

レジオネラ菌検査市場の成長は、市場促進要因・課題の組み合わせによって影響を受けています。技術の進歩、規制の変更、社会的認知度の向上が主要な促進要因である一方、高コスト、複雑な業界規制、標準化の欠如が大きな課題となっています。これらの要因を理解することは、この分野を理解し、成長機会を見出すために不可欠です。

レジオネラ菌検査市場の促進要因

1.技術の進歩：最新技術の使用により、レジオネラ菌検査の精度が大幅に向上しました。定量ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、自動化システムなどの高度な手順により、検出効率が向上し、所要時間が短縮されました。このような技術の開発は、迅速で信頼性の高いスクリーニング結果に対する要求が原動力となっています。

2.規制要件の厳格化：ますます厳しくなる規制要件により、検査室や施設はコンプライアンスを確保するため、より洗練された方法を採用せざるを得なくなっています。最新のガイドラインを遵守することで、検査結果の品質と信頼性が高まり、より大規模な公衆衛生管理が可能になります。この動向は、高度なレジオネラ菌検査ソリューションに対する需要の高まりに寄与しています。

3.公衆衛生意識の高まり：レジオネラおよびレジオネラ症に対する公衆の意識の高まりが、検査サービスに対する需要を押し上げています。レジオネラ菌に関連するリスクに対する認識が高まるにつれ、予防と定期的な検査に焦点が当てられるようになり、それ別市場が拡大し、高度な検査技術への投資が促進されます。

4.ヘルスケアインフラの拡大：特に新興国市場におけるヘルスケアインフラの拡大は、レジオネラ菌検査プログラムの開発と実施につながっています。水の安全性と公衆衛生インフラへの投資は、検査ソリューションへの需要を高め、全体的な疾病管理を強化します。この拡大はレジオネラ菌検査市場の成長に重要な役割を果たしています。

5.環境モニタリングとの統合：レジオネラ菌検査を環境モニタリングシステムと統合することで、包括的な水質管理が保証され、潜在的なアウトブレイクを事前に検出することができます。この統合はレジオネラ菌検査の有効性を高め、疾病予防へのより積極的なアプローチに貢献し、それ別市場を拡大します。

レジオネラ菌検査市場の課題：

1.初期コストの高さ：高度な検査技術は高価である可能性があり、一部の検査室や施設にとっては手が出ないものとなります。このコスト障壁は、特に予算に制約のある市場において、レジオネラ菌検査ソリューションの普及を制限する可能性があります。市場アクセスを改善するためには、検査の質を落とすことなく、このようなコスト障壁を低減する努力が必要です。

2.複雑な規制要件：レジオネラ菌検査に関する規制要件の複雑さは、市場参入の障壁となり、開発コストを増大させます。試験所は、製品が要求基準を満たすことを保証するために、様々な規制を遵守しなければならないです。この複雑さが業界の成長を遅らせ、ユーザーからの抵抗を生み、新しいソリューションの採用を妨げる可能性があります。

3.限られた標準化：レジオネラ菌検査が標準化されていないため、検査機関別結果にばらつきが生じ、検査結果の信頼性と信用性が損なわれる可能性があります。標準化された検査手順を確立し実施することで、結果の一貫性が向上し、レジオネラ菌検査ソリューションに対する信頼が高まるため、市場の成長が促進されます。

レジオネラ菌検査市場は、技術の進歩、規制要件の厳格化、公衆衛生意識の高まり、ヘルスケア・インフラの拡大、環境モニタリング・システムとの検査の統合によって牽引されています。しかし、高コスト、複雑な規制、標準化の欠如といった課題が市場の成長を妨げています。これらの課題を克服しつつ成長促進要因を活用することが、検査実務の進展と市場機会の拡大に不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界のレジオネラ菌検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019-2024年）と予測（2025-2031年）
• 世界のレジオネラ菌検査市場の動向（2019～2024年）と予測（2025～2031年）
• レジオネラ菌検査の世界市場、検査タイプ別
  • 培養方法
  • 尿中抗原検査
  • 直接蛍光抗体検査
  • その他
• レジオネラ菌検査の世界市場、用途別
  • 水質検査
  • 体外診断検査
  • その他
• レジオネラ菌検査の世界市場、最終用途別
  • 病院
  • 診断検査室
  • 水産業
  • その他

第4章 2019年から2031年までの市場動向と予測分析、地域別

• レジオネラ菌検査市場、地域別
• 北米のレジオネラ菌検査市場
• 欧州のレジオネラ菌検査市場
• アジア太平洋地域のレジオネラ菌検査市場
• その他地域のレジオネラ菌検査市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のレジオネラ菌検査市場の成長機会、検査タイプ別
  • 世界のレジオネラ菌検査市場の成長機会、用途別
  • 世界のレジオネラ菌検査市場の成長機会、最終用途別
  • 世界のレジオネラ菌検査市場の成長機会、地域別
• 世界のレジオネラ菌検査市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のレジオネラ菌検査市場の能力拡大
  • 世界のレジオネラ菌検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Abbott
• Beckman Coulter
• BD
• Bio-Rad Laboratories
• BIOMERIEUX
• Eiken Chemical
• Hologic
• Pro Lab Diagnostics
• QIAGEN
• F. Hoffmann-La Roche

The future of the global legionella testing market looks promising with opportunities in the hospital, diagnostic laboratory, and water industry markets. The global legionella testing market is expected to reach an estimated $488.2 million by 2031 with a CAGR of 7.8% from 2025 to 2031. The major drivers for this market are the growing occurrences of pneumonia and diseases associated with Legionella bacteria, as well as the rising stricter regulations on routine water testing.

• Lucintel forecasts that, within the application category water testing will remain the larger segment over the forecast period.
• Within the end-use category, the water industry will remain the largest segment over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Legionella Testing Market

Upcoming trends in the legionella testing market denote technological advances, regulatory modifications, and increased attention to public health. These shifts change the way Legionella is detected and managed, drive invention as well as enhance testing precision and speed. Understanding these ideas will be important for stakeholders who want to remain relevant within a constantly changing market.

• Advanced Molecular Diagnostics: Advanced molecular diagnostics have greater sensitivity and specificity in detecting legionella bacteria compared to conventional ways leading to quicker and more accurate results from these tests. These technologies facilitate the detection of small bacterial quantities alongside detailed genomic information that is useful for studying outbreak epidemiology within a public health context.
• Automation and High Throughput Testing: Automation as well as high-throughput systems help streamline testing procedures resulting in raise efficiency while reducing human errors. They are also able to handle large amounts of samples at once hence ideal in hospitals or water treatment plant expansions. The increased throughput capacity coupled with automation increases general turnaround time limits.
• Enhanced Regulatory Requirements: Improved regulatory requirements urge laboratories to employ superior technologies for their diagnostic approaches. Adherence with any updated guidelines assures better quality tests that are reliable and necessary for disease control or prevention purposes. In order to meet these standards and retain compliance labs must invest in new technologies and processes.
• Integration with Environmental Monitoring Systems: Integrating Legionella tests into environmental monitoring systems expands the scope of water quality management. It allows for real-time monitoring and early detection of potential outbreaks of legionella to be proactive in preventing disease transmission. This improves the overall effectiveness of water safety programs and public health measures.
• Increased Focus on Preventative Measures: There is an increased emphasis on prevention strategies for managing Legionella risks, including regular testing and maintenance of water systems. Proactive testing can help identify possible trouble spots before they cause outbreaks, leading to better health outcomes for the public. This trend supports robust testing programs and investment in prevention technologies and practices.

Emerging trends in the industry such as advanced molecular diagnostics, automation, enhanced regulatory requirements, integration with environmental monitoring systems, and increased focus on preventative measures are revolutionizing the market for tests for legionella. Therefore these trends improve the accuracy and efficiency of tests as well as enhance general management within public health when it comes to controlling legionella.

Recent Developments in the Legionella Testing Market

The recent developments in the legionella testing market reflect technological advancements, regulatory changes, and a higher priority given to public health issues. These developments highlight how the industry is responding to emerging demands and challenges that have necessitated improvements in reliability, efficiency in testing, and other factors critical to managing Legionella risks. The following section examines key trends influencing the current state of the industry.

• Adoption of Advanced Molecular Techniques: The Legionella detection process has improved with the adoption of advanced molecular techniques such as polymerase chain reaction (PCR) and Next-Generation Sequencing (NGS). These technologies offer high sensitivity and specificity, enabling rapid identification of Legionella bacteria even in low concentrations. The use of molecular diagnostics is increasing, improving outbreak response and surveillance, and making it easier to track and manage Legionella-related health risks.
• Implementation of Automated Testing Systems: Efficiency in the legionella testing market has been enhanced with the implementation of automated testing systems, which reduce manual errors. These systems allow for high-throughput testing with faster turnaround times, simplifying testing processes. This is especially beneficial for large-scale facilities, such as hospitals and water treatment plants, that need to test many samples at once, allowing for effective management and prevention of outbreaks.
• Strengthening of Regulatory Frameworks: Updates to regulatory frameworks have introduced more stringent guidelines for Legionella testing and management. Regulatory agencies are pushing for advanced testing methods, demanding higher standards in water quality monitoring and laboratory testing. Compliance with these updated regulations makes Legionella detection more accurate and reliable, helping to improve public health outcomes and manage Legionellosis risks more effectively.
• Expansion of Testing Infrastructure: The establishment of new laboratories and the upgrading of existing ones have addressed the growing demand for Legionella testing through the expansion of infrastructure. This trend is particularly prominent in developing markets, where testing capacities are being enhanced to provide better access to quality diagnostic services. The expansion of infrastructure enables effective surveillance and control measures for Legionellosis, supporting better disease prevention efforts.
• Focus on Preventative Strategies: Preventive strategies have become a key focus in managing Legionellosis risks, including periodic sampling, testing, and maintenance of water systems. Proactive testing helps identify potential issues before they lead to outbreaks, supporting early intervention and mitigation efforts. This has led to the development of more robust testing programs for water authorities, with more investments in new technologies and practices that improve water safety and public health.

Recent developments in the legionella testing market, such as the adoption of advanced molecular techniques like NGS and PCR, the implementation of automated systems, and the focus on preventative strategies, are significantly improving testing accuracy and efficiency. These developments also enhance the overall management of Legionella risks, leading to better public health outcomes and driving market growth.

Strategic Growth Opportunities for Legionella Testing Market

Strategic growth opportunities in the legionella testing market may result from advances or innovations that enable wider penetration into new markets and improvement of current practices. The global markets for these opportunities are wide-ranging indicating different sectors with potential for technology improvements or regulatory changes necessary for public health goals.

• Development of Advanced Testing Technologies: Advanced testing technologies can significantly increase sensitivity, specificity, and efficiency in terms of detecting legionella. By investing in these technologies, accurate and prompt results can be produced thus meeting rising demand which are reliable as well as quick. It also supports the expansion of capacity for diagnosis and overall disease prevention/control.
• Penetration into Emerging Markets: Taking legionella testing services into new markets generates substantial growth prospects to expand legionella testing business. By focusing on these areas, market expansion and better health outcomes linked to the improvement of public access to quality testing services and addressing emerging health concerns can be promoted. This change promotes global growth and enhances disease control initiatives.
• Integrated Environmental Monitoring Systems: Integrating Legionella testing with environmental monitoring facilitates comprehensive management of water quality as well as real-time monitoring. By so doing, this path enables prevention of future diseases and early warning about a possible outbreak of legionnaires' disease. Such integration improves the overall efficacy and reliability of the screening programs
• A Greater Emphasis on Preventative and Proactive Testing Strategies: By concentrating on preventive maintenance measures like water system upkeep, it becomes easier to identify and address likely causes of outbreaks before they occur. In effect, this helps improve public health outcomes while supporting stronger test programs. Investing in preventive strategies improves the management of diseases while decreasing the number of cases attributable to legionnaire's disease.
• Augmented Regulatory Compliance Solutions: Providing solution platforms that allow for adherence to ever-tightening rules results in the adoption of sophisticated examination methods at high-quality standards. Improved compliance mechanisms address regulation challenges in order to promote industry growth within this context of other broader changes that concern overall means through which one does analysis work. This opportunity supports more effective development as well as reliable screening programs.

Growth opportunities in the market of legionella testing, such as advanced technology development, new market penetration, integration with environmental monitoring systems, emphasis on preventive testing, and enhanced regulatory compliance may lead to significant expansion of the market. The above strategies can help provide better management for legionnaires disease and improve test result accuracy.

Legionella Testing Market Driver and Challenges

The growth of the legionella testing market is influenced by a combination of drivers and challenges. Technological advancements, changes in regulations, and increased public awareness are key drivers, while high costs, complex industry regulations, and lack of standardization present significant challenges. Understanding these factors is essential to navigating this space and identifying growth opportunities.

Factors Driving the Legionella Testing Market:

1. Technological Advancements: The use of modern techniques has significantly increased the precision of legionella testing. Advanced procedures such as quantitative polymerase chain reaction (PCR), next-generation sequencing (NGS), and automated systems have improved detection efficiency and reduced turnaround times. The development of these technologies is driven by the demand for rapid and reliable screening results, which are essential, especially when cost considerations come into play.

2. Stricter Regulatory Requirements: Increasingly stringent regulatory requirements have forced laboratories and facilities to adopt more sophisticated methods to ensure compliance. Adhering to updated guidelines ensures higher quality and reliability of test results, which supports public health management at larger scales. This trend contributes to the growing demand for advanced Legionella testing solutions.

3. Increased Public Health Awareness: Rising public awareness of Legionella and Legionnaires' disease has driven the demand for testing services. As the recognition of the risks associated with Legionella increases, so does the focus on prevention and periodic testing, thereby expanding the market and encouraging investment in advanced testing technologies.

4. Expansion of Healthcare Infrastructure: The expansion of healthcare infrastructure, particularly in emerging markets, has led to the development and implementation of legionella testing programs. Investments in water safety and public health infrastructure increase the demand for testing solutions and enhance overall disease management. This expansion plays a crucial role in growing the market for Legionella testing.

5. Integration with Environmental Monitoring: The integration of legionella testing with environmental monitoring systems ensures comprehensive water quality management and the ability to detect potential outbreaks before they occur. This integration enhances the effectiveness of Legionella testing and contributes to a more proactive approach to disease prevention, thereby expanding the market.

Challenges in the Legionella Testing Market:

1. High Initial Costs: Advanced testing technologies can be expensive, making them unaffordable for some laboratories and facilities. This cost barrier can limit the penetration of legionella testing solutions, particularly in markets with budget constraints. To improve market access, efforts should be made to reduce these cost barriers without compromising the quality of testing.

2. Complex Regulatory Requirements: The complexity of regulatory requirements for legionella testing can create barriers to market entry and increase development costs. Laboratories must comply with various regulations to ensure their products meet the required standards. This complexity may slow industry growth and create resistance from users, hindering the adoption of new solutions.

3. Limited Standardization: The lack of standardized practices for legionella testing can lead to disparities in results across different laboratories, undermining the reliability and credibility of test outcomes. Establishing and enforcing standardized testing procedures would improve the consistency of results and increase trust in Legionella testing solutions, thus supporting market growth.

The legionella testing market is driven by technological advancements, stricter regulatory requirements, increased public health awareness, the expansion of healthcare infrastructure, and the integration of testing with environmental monitoring systems. However, challenges such as high costs, complex regulations, and lack of standardization hinder market growth. Overcoming these challenges while capitalizing on the growth drivers will be crucial for advancing testing practices and expanding market opportunities.

List of Legionella Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies legionella testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the legionella testing companies profiled in this report include-

• Abbott
• Beckman Coulter
• BD
• Bio-Rad Laboratories
• BIOMERIEUX
• Eiken Chemical
• Hologic
• Pro Lab Diagnostics
• QIAGEN
• F. Hoffmann-La Roche

Legionella Testing by Segment

The study includes a forecast for the global legionella testing market by test type, application, end use, and region.

Legionella Testing Market by Test Type [Analysis by Value from 2019 to 2031]:

• Culture Methods
• Urinary Antigen Tests
• Direct Fluorescent Antibody Tests
• Others

Legionella Testing Market by Application [Analysis by Value from 2019 to 2031]:

• Water Testing
• IVD Testing
• Others

Legionella Testing Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Diagnostic Laboratories
• Water Industries
• Others

Legionella Testing Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Legionella Testing Market

The increased awareness of Legionnaires' disease, stringent regulatory requirements, and technological advancements have led to significant developments in the legionella testing market worldwide. These improvements are making testing methods more accurate and efficient, which helps manage and prevent outbreaks more effectively. This overview highlights recent changes in the U.S., China, Germany, India, and Japan markets, reflecting each country's distinct progress and challenges.

• United States: A recent development in the United States is the adoption of advanced molecular techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), for highly accurate and rapid detection of legionella bacteria. This has led to increased demand for improved testing solutions, especially as the Environmental Protection Agency (EPA) updates guidelines and standards for water testing. Furthermore, there is growing interest in automated test platforms, which may be used in large-scale facilities such as hospitals and water treatment plants, thus improving the accuracy and speed of legionella detection and enhancing public health safety.
• China: The drive to improve healthcare services and meet international standards has been a major factor in recent trends in China's legionella testing market. For example, both private and public sector players have increased their testing capacity by setting up new laboratories or upgrading existing ones. The Chinese government has enacted stricter regulations on water quality monitoring, resulting in the implementation of more sophisticated diagnostic methods. Additionally, there is increased cooperation with other countries to standardize test procedures and improve overall detection capabilities to better manage the pathogen.
• Germany: Advancements in legionella testing in Germany embrace high-throughput screening technologies integrated with enhanced detection approaches. The country has responded to outbreaks by implementing stricter control measures for its population and tightening regulatory standards. New developments include the use of rapid immunoassay technologies and improvements in sample preparation techniques to speed up turnaround times. To ensure a continuous supply of reliable data, Germany has made significant investments in cutting-edge technologies and continues to maintain high standards in public health.
• India: Driven by increasing awareness and regulatory pressure, India has seen growth in its legionella testing market. Recent developments include the introduction of affordable testing solutions and the establishment of more testing facilities, both in urban and rural areas. Public facilities are required by the Indian government to regularly test their water quality, leading to the adoption of advanced testing technologies. Additionally, there is a focus on training and capacity building for laboratory personnel to improve the accuracy and reliability of tests. These advancements have contributed to better management of Legionnaires' disease outbreaks in the country.
• Japan: Japan's approach to the legionella testing market is characterized by technological innovations aimed at preventing disease outbreaks before they occur. Recent innovations include the use of advanced molecular diagnostics and automated assay systems that enhance both speed and accuracy in legionella detection. New regulations have prompted laboratories to invest in more advanced devices, thereby upgrading their diagnostic capacities. By making significant efforts to improve methods for legionella testing, the Japanese government has placed a strong emphasis on research as a key strategy for addressing future challenges, including a better understanding of molecular biology. These developments are expected to improve management practices, reduce the occurrence of Legionella outbreaks, and minimize associated risk factors in Japan's environment.

Features of the Global Legionella Testing Market

Market Size Estimates: Legionella testing market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Legionella testing market size by test type, application, end use, and region in terms of value ($M).

Regional Analysis: Legionella testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, applications, end uses, and regions for the legionella testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the legionella testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the legionella testing market by test type (culture methods, urinary antigen tests, direct fluorescent antibody tests, and others), application (water testing, IVD testing, and others), end use (hospitals, diagnostic laboratories, water industries, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Legionella Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Legionella Testing Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Legionella Testing Market by Test Type
  • 3.3.1: Culture Methods
  • 3.3.2: Urinary Antigen Tests
  • 3.3.3: Direct Fluorescent Antibody Tests
  • 3.3.4: Others
• 3.4: Global Legionella Testing Market by Application
  • 3.4.1: Water Testing
  • 3.4.2: IVD Testing
  • 3.4.3: Others
• 3.5: Global Legionella Testing Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Water Industries
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Legionella Testing Market by Region
• 4.2: North American Legionella Testing Market
  • 4.2.1: North American Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.2.2: North American Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.3: European Legionella Testing Market
  • 4.3.1: European Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.3.2: European Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.4: APAC Legionella Testing Market
  • 4.4.1: APAC Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.4.2: APAC Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.5: ROW Legionella Testing Market
  • 4.5.1: ROW Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.5.2: ROW Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Legionella Testing Market by Test Type
  • 6.1.2: Growth Opportunities for the Global Legionella Testing Market by Application
  • 6.1.3: Growth Opportunities for the Global Legionella Testing Market by End Use
  • 6.1.4: Growth Opportunities for the Global Legionella Testing Market by Region
• 6.2: Emerging Trends in the Global Legionella Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Legionella Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Legionella Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: Beckman Coulter
• 7.3: BD
• 7.4: Bio-Rad Laboratories
• 7.5: BIOMERIEUX
• 7.6: Eiken Chemical
• 7.7: Hologic
• 7.8: Pro Lab Diagnostics
• 7.9: QIAGEN
• 7.10: F. Hoffmann-La Roche